Theravance Biopharma Net Profit Margin 2012-2020 | TBPH

Theravance Biopharma net profit margin from 2012 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Theravance Biopharma Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-03-31 $0.09B $-0.25B -283.91%
2019-12-31 $0.07B $-0.24B -329.17%
2019-09-30 $0.06B $-0.22B -374.58%
2019-06-30 $0.06B $-0.22B -370.00%
2019-03-31 $0.06B $-0.22B -391.23%
2018-12-31 $0.06B $-0.22B -358.33%
2018-09-30 $0.05B $-0.25B -514.29%
2018-06-30 $0.04B $-0.26B -650.00%
2018-03-31 $0.02B $-0.29B -1357.14%
2017-12-31 $0.02B $-0.29B -1781.25%
2017-09-30 $0.02B $-0.27B -1558.82%
2017-06-30 $0.03B $-0.23B -725.00%
2017-03-31 $0.03B $-0.21B -645.45%
2016-12-31 $0.05B $-0.19B -395.83%
2016-09-30 $0.05B $-0.17B -365.22%
2016-06-30 $0.04B $-0.18B -476.32%
2016-03-31 $0.04B $-0.18B -455.00%
2015-12-31 $0.04B $-0.18B -433.33%
2015-09-30 $0.04B $-0.20B -515.38%
2015-06-30 $0.03B $-0.21B -611.76%
2015-03-31 $0.03B $-0.22B -726.67%
2014-12-31 $0.01B $-0.24B -2145.45%
2014-09-30 $0.01B $-0.22B -2160.00%
2014-06-30 $0.00B $-0.20B -5075.00%
2014-03-31 $0.00B $-0.18B -18400.00%
2013-12-31 $0.00B $-0.16B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.107B $0.073B
Theravance Biopharma, Inc. is a biopharmaceutical company. It is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including bacterial infections, central nervous system (CNS)/pain, respiratory disease, and gastrointestinal (GI) motility dysfunction. Theravance Biopharma, Inc. is based in George Town, Cayman Islands.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.116B 42.73
Takeda Pharmaceutical (TAK) Japan $57.348B 9.99
Astellas Pharma (ALPMY) Japan $29.096B 14.74
Eisai (ESALY) Japan $26.083B 22.04
UCB SA (UCBJF) Belgium $24.702B 0.00
Merck (MKGAF) Germany $17.448B 22.88
Catalent (CTLT) United States $13.567B 52.45
Grifols, S.A (GRFS) Spain $11.998B 14.66
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.497B 40.63
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.754B 0.00
Ionis Pharmaceuticals (IONS) United States $7.558B 47.88
Orion OYJ (ORINY) Finland $7.077B 24.56
Jazz Pharmaceuticals (JAZZ) Ireland $7.007B 11.59
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
United Therapeutics (UTHR) United States $4.927B 11.39
Arrowhead Pharmaceuticals (ARWR) United States $4.130B 0.00
Evotec AG (EVTCY) Germany $4.113B 110.84
FibroGen (FGEN) United States $4.080B 0.00
Hypermarcas (HYPMY) Brazil $3.873B 14.25
Nektar Therapeutics (NKTR) United States $3.820B 0.00
ChemoCentryx (CCXI) United States $3.447B 0.00
PTC Therapeutics (PTCT) United States $3.252B 0.00
Sage Therapeutics (SAGE) United States $2.768B 0.00
Pacira BioSciences (PCRX) United States $2.607B 68.53
Taro Pharmaceutical Industries (TARO) Israel $2.434B 11.78
Cronos Group (CRON) Canada $2.029B 0.00
Xencor (XNCR) United States $1.815B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.810B 0.00
USANA Health Sciences (USNA) United States $1.704B 16.05
Revolution Medicines (RVMD) United States $1.682B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.622B 11.31
Indivior (INVVY) United States $1.605B 19.90
Corcept Therapeutics (CORT) United States $1.597B 14.70
Heron Therapeutics (HRTX) United States $1.408B 0.00
Akebia Therapeutics (AKBA) United States $1.390B 0.00
Zogenix (ZGNX) United States $1.362B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.309B 12.49
CLINIGEN GP (CLIGF) United Kingdom $1.142B 0.00
Translate Bio (TBIO) United States $1.126B 0.00
Karyopharm Therapeutics (KPTI) United States $1.117B 0.00
VAXART, INC (VXRT) United States $1.026B 0.00
Esperion Therapeutics (ESPR) United States $1.022B 0.00
Tilray (TLRY) Canada $0.995B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.961B 600.25
Altimmune (ALT) United States $0.835B 0.00
Endo (ENDP) Ireland $0.765B 1.13
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.729B 0.00
ImmunoGen (IMGN) United States $0.703B 0.00
Trillium Therapeutics (TRIL) Canada $0.685B 0.00
Collegium Pharmaceutical (COLL) United States $0.652B 0.00
Flexion Therapeutics (FLXN) United States $0.617B 0.00
Aerie Pharmaceuticals (AERI) United States $0.600B 0.00
Molecular Templates (MTEM) United States $0.597B 0.00
Siga Technologies (SIGA) United States $0.592B 63.17
Radius Health (RDUS) United States $0.585B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.561B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.560B 0.00
Ocular Therapeutix (OCUL) United States $0.533B 0.00
Ardelyx (ARDX) United States $0.507B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.499B 24.87
Innate Pharma SA (IPHYF) France $0.489B 0.00
DURECT (DRRX) United States $0.469B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.458B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.441B 10.94
Rigel Pharmaceuticals (RIGL) United States $0.439B 0.00
TherapeuticsMD (TXMD) United States $0.428B 0.00
Organogenesis Holdings (ORGO) United States $0.409B 0.00
Heat Biologics (HTBX) United States $0.360B 0.00
Redhill Biopharma (RDHL) Israel $0.345B 0.00
Harpoon Therapeutics (HARP) United States $0.336B 0.00
Calithera Biosciences (CALA) United States $0.332B 0.00
OptiNose (OPTN) United States $0.317B 0.00
IMV INC (IMV) Canada $0.316B 0.00
Concert Pharmaceuticals (CNCE) United States $0.310B 0.00
Rafael Holdings (RFL) United States $0.303B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.294B 0.00
PROFOUND MEDICL (PROF) Canada $0.288B 0.00
MEI Pharma (MEIP) United States $0.288B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.269B 0.00
Lannett Co Inc (LCI) United States $0.255B 5.58
Aquestive Therapeutics (AQST) United States $0.234B 0.00
CASI Pharmaceuticals (CASI) United States $0.231B 0.00
Nature's Sunshine Products (NATR) United States $0.212B 20.92
KalVista Pharmaceuticals (KALV) United States $0.210B 0.00
Taiwan Liposome (TLC) Taiwan $0.194B 0.00
Nivalis Therapeutics (ALPN) United States $0.193B 0.00
Onconova Therapeutics (ONTX) United States $0.189B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.184B 0.00
Jounce Therapeutics (JNCE) United States $0.172B 8.13
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.135B 0.00
Xeris Pharmaceuticals (XERS) United States $0.132B 0.00
Champions Oncology (CSBR) United States $0.120B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.117B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.107B 0.00
Lipocine (LPCN) United States $0.103B 0.00
Hemispherx BioPharma (AIM) United States $0.100B 0.00
Otonomy (OTIC) United States $0.100B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.100B 0.00
Biomerica (BMRA) United States $0.099B 0.00
MediWound (MDWD) Israel $0.099B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.099B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
CTI BioPharma (CTIC) United States $0.096B 0.00
Aclaris Therapeutics (ACRS) United States $0.093B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.091B 0.00
ElectroCore (ECOR) United States $0.084B 0.00
Addex Therapeutics (ADXN) Switzerland $0.080B 0.00
Recro Pharma (REPH) United States $0.079B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
CV Sciences (CVSI) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.066B 0.00
Infinity Pharmaceuticals (INFI) United States $0.063B 0.00
PolarityTE (PTE) United States $0.060B 0.00
GTx (ONCT) United States $0.059B 0.00
Sundial Growers (SNDL) Canada $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Novan (NOVN) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.82
AgeX Therapeutics (AGE) United States $0.049B 0.00
Jaguar Animal Health (JAGX) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
IsoRay (ISR) United States $0.045B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.043B 8.19
Opiant Pharmaceuticals (OPNT) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.034B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
India Globalization Capital (IGC) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Vical (BBI) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 36.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Midatech Pharma (MTP) United Kingdom $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00